Literature DB >> 14319485

EVALUATION OF PHOSPHORUS 32 FOR INTRACTABLE PAIN SECONDARY TO PROSTATIC CARCINOMA METASTASES.

D P JOSHI, W H SEERY, L G GOLDBERG, L GOLDMAN.   

Abstract

Entities:  

Keywords:  GERIATRICS; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; PAIN; PALLIATIVE TREATMENT; PHOSPHORUS ISOTOPES; PROSTATIC NEOPLASMS

Mesh：

Substances：

Year:  1965        PMID： 14319485     DOI： 10.1001/jama.1965.03090070071032

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer.

Authors:  A J Suarez; D L Lamm; H M Radwin; M Sarosdy; G Clark; C K Osborne
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Radioactive phosphorus.

Authors: 
Journal:  Br Med J       Date:  1967-04-22

3.  Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.

Authors:  W Y Lin; C P Lin; S J Yeh; B T Hsieh; Z T Tsai; G Ting; T C Yen; S J Wang; F F Knapp; M G Stabin
Journal:  Eur J Nucl Med       Date:  1997-06

Review 4.  Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Authors:  George Sgouros; Lisa Bodei; Michael R McDevitt; Jessie R Nedrow
Journal:  Nat Rev Drug Discov       Date:  2020-07-29       Impact factor: 84.694

5.  A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.

Authors:  Zin W Myint; Riham El Khouli; Bryan Lemieux; Donglin Yan; William H St Clair; Xiaoqi Liu; Charles A Kunos
Journal:  BMC Cancer       Date:  2022-04-15       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.